People · Operator
Named in public records as an officer, director or promoter · active 2018–2021 · Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Precision Medicine Group Holdings, Inc. | — | Other Health Care | Series C | $119.8M | $671.1M | 2018 |
Matthew J. Hobart at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matthew J. Hobart on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Benjamin D. Levy | 1 | 2 |
| Christopher J. Hadley | 1 | 2 |
| Julia Kahr | 1 | 2 |
| Anushka J. Sunder | 1 | 1 |
| Jake B. Graetz | 1 | 1 |
| Ethan Leder | 1 | 1 |
| Mark Clein | 1 | 1 |
| John B. Mariano, Jr. | 1 | 1 |
| Annie J. Lamont | 1 | 1 |
| Paul J. Vigano | 1 | 1 |
| Jesse T. Glossner | 1 | 1 |
| Martin J. Coulter | 1 | 1 |
| Brent J. Gunderson | 1 | 1 |
| Matthew T. DeZee | 1 | 1 |
| Charles T. Clark | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.